PD-1 and PD-L1 Inhibitors Clinical Trial Pipeline Analysis Demonstrates 180+ Key Companies on the Horizon Expected to Transform the Oncology Space | DelveInsight
GSK's RSV Vaccine, AREXVY, Approved in US for Expanded Age Indication in Adults Aged 18-49 Years at Increased Risk
Forbion Announces Second Exit from Forbion Growth Fund III Following $2.2 Billion Acquisition of RAPT Therapeutics by GSK
PIVOT-PO Phase 3 Data Show Tebipenem HBr's Potential as the First Oral Carbapenem Antibiotic for Patients with Complicated Urinary Tract Infections
New Local Data in GSK and IQVIA's Vaccine Track Supports Smarter Public Health Action at the Community Level
Nine Mile Metals DDH WD-26-07 Intersects High Grade VMS Zones Including 24m of 2.77% Cu-Eq and 9.2m of 4.14% Cu-Eq
NevGold Expands Recent Mineral Resource Estimate With First 2026 Drillholes; 1.16% Antimony Over 3.0 Meters Within 1.38 g/t AuEq Over 50.3 Meters From Surface
SAGA Metals Completes Mineral Resource Estimate Drill Program at Radar Critical Minerals Project in Labrador
